Hilf, N. et al. Actively customized vaccination trial for newly identified glioblastoma. Nature 565, 240–245 (2019).
Chen, L. et al. Bacterial cytoplasmic membranes synergistically improve the antitumor exercise of autologous most cancers vaccines. Sci. Transl. Med. 13, eabc2816 (2021).
Möller, A. & Lobb, R. J. The evolving translational potential of small extracellular vesicles in most cancers. Nat. Rev. Most cancers 20, 697–709 (2020).
Xu, R. et al. Extracellular vesicles in cancer-implications for future enhancements in most cancers care. Nat. Rev. Clin. Oncol. 15, 617–638 (2018).
Buzas, E. I. The roles of extracellular vesicles within the immune system. Nat. Rev. Immunol. 23, 236–250 (2023).
Kalluri, R. & LeBleu, V. S. The biology, perform, and biomedical purposes of exosomes. Science 367, eaau6977 (2020).
Wang, S. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 13, eabb6981 (2021).
Xi, X. et al. Self-healing microcapsules synergetically modulate immunization microenvironments for potent most cancers vaccination. Sci. Adv. 6, eaay7735 (2020).
Rao, L. et al. Hybrid mobile membrane nanovesicles amplify macrophage immune responses towards most cancers recurrence and metastasis. Nat. Commun. 11, 4909 (2020).
Shimizu, A. et al. Exosomal CD47 performs a necessary position in immune evasion in ovarian most cancers. Mol. Most cancers Res. 19, 1583–1595 (2021).
Sockolosky, J. T. et al. Sturdy antitumor responses to CD47 blockade require adaptive immune stimulation. Proc. Natl Acad. Sci. USA 113, E2646–E2654 (2016).
Vonderheide, R. H. CD47 blockade as one other immune checkpoint remedy for most cancers. Nat. Med. 21, 1122–1123 (2015).
Wilschut, J., Duezguenes, N. & Papahadjopoulos, D. Calcium/magnesium specificity in membrane fusion: kinetics of aggregation and fusion of phosphatidylserine vesicles and the position of bilayer curvature. Biochemistry 20, 3126–3133 (1981).
Zhu, L. et al. In vitro choice of extremely environment friendly G-quadruplex-based DNAzymes. Anal. Chem. 84, 8383–8390 (2012).
Kong, D. M., Xu, J. & Shen, H. X. Constructive results of ATP on G-Quadruplex-hemin DNAzyme-mediated reactions. Anal. Chem. 82, 6148–6153 (2010).
Bhuyan, S. Okay. et al. Directed evolution of a G-quadruplex peroxidase DNAzyme and utility in proteomic DNAzyme-aptamer proximity labeling. J. Am. Chem. Soc. 145, 12726–12736 (2023).
Veglia, F. et al. Lipid our bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in most cancers. Nat. Commun. 8, 2122 (2017).
Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in most cancers: insights into tumour immunogenicity and immune evasion. Nat. Rev. Most cancers 21, 298–312 (2021).
Feng, M. et al. Phagocytosis checkpoints as new targets for most cancers immunotherapy. Nat. Rev. Most cancers 19, 568–586 (2019).
Chen, Y. C., Shi, W., Shi, J. J. & Lu, J. J. Progress of CD47 immune checkpoint blockade brokers in anticancer remedy: a hematotoxic perspective. J. Most cancers Res. Clin. Oncol. 148, 1–14 (2022).
Lu, Y. et al. Immunological conversion of strong tumours utilizing a bispecific nanobioconjugate for most cancers immunotherapy. Nat. Nanotech 17, 1332–1341 (2022).
Hauser, A. Okay. et al. Focused iron oxide nanoparticles for the enhancement of radiation remedy. Biomaterials 105, 127–135 (2016).
Mulens-Arias, V., Rojas, J. M., Pérez-Yagüe, S., Morales, M. P. & Barber, D. F. Barber polyethylenimine-coated SPIONs set off macrophage activation by TLR-4 signaling and ROS manufacturing and modulate podosome dynamics. Biomaterials 52, 494–506 (2015).
Batool, F. et al. Biologically synthesized iron nanoparticles (FeNPs) from Phoenix dactylifera have anti-bacterial actions. Sci. Rep. 11, 22132–22140 (2021).
Jiang, S. et al. Synergistic anticancer remedy by ovalbumin encapsulation‐enabled tandem reactive oxygen species era. Angew. Chem. Int. Ed. Engl. 59, 20008–20016 (2020).
Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557–569 (2012).
Mantegazza, A. R. et al. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells. Blood 112, 4712–4722 (2008).
Savina, A. et al. NOX2 controls phagosomal pH to control antigen processing throughout cross presentation by dendritic cells. Cell 126, 205–218 (2006).
Kitai, Y. et al. DNA-containing exosomes derived from most cancers cells handled with topotecan activate a STING-dependent pathway and reinforce antitumor immunity. J. Immunol. 198, 1649–1659 (2017).
Zhang, H. et al. Cell-free tumor microparticle vaccines stimulate dendritic cells by way of cGAS/STING signaling tumor cell-derived microparticles as vaccine. Most cancers Immunol. Res. 3, 196–205 (2015).
Voets, E. et al. Useful characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα-CD47 innate immune checkpoint. J. Immunother. Most cancers 7, 340–354 (2019).
Sikic, B. I. et al. First-in-human, first-in-class section I trial of the anti-CD47 antibody hu5F9-G4 in sufferers with superior cancers. J. Clin. Oncol. 37, 946–953 (2019).
DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369–382 (2019).
Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in most cancers development and response to immunotherapy. Nat. Med. 27, 212–224 (2021).
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism within the tumor microenvironment. Cell. Metab. 30, 36–50 (2019).
Gu, Z. et al. Mechanism of iron oxide-induced macrophage activation:tThe impression of composition and the underlying signaling pathway. J. Am. Chem. Soc. 141, 6122–6126 (2019).
Zhang, Y. et al. ROS play a important position within the differentiation of alternatively activated macrophages and the incidence of tumor-associated macrophages. Cell Res. 23, 898–914 (2013).
Gao, Y. et al. Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in sufferers with extrahepatic cholangiocarcinoma. Nat. Biomed. Eng. 4, 743–753 (2020).
Bangert, C. et al. Persistence of mature dendritic cells, TH2A, and Tc2 cells characterize clinically resolved atopic dermatitis below IL-4Rα blockade. Sci. Immunol. 6, eabe2749 (2021).
Woller, N. et al. Virus-induced tumor irritation facilitates efficient DC most cancers immunotherapy in a Treg-dependent method in mice. J. Clin. Make investments. 121, 2570–2582 (2011).
Liu, Y. et al. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to boost anti-PD-L1 remedy for malignant pleural effusion. Nat. Nanotechnol. 17, 206–216 (2022).
Bard, M. P. et al. Proteomic evaluation of exosomes remoted from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 31, 114–121 (2004).
Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is related to anti-PD-1 response. Nature 560, 382–386 (2018).
Xian, Y. et al. Controllable meeting of enzymes for multiplexed lab-on-a-Chip bioassays with a tunable detection vary. Angew. Chem. Int. Ed. 130, 7625–7629 (2018).
Tian, F., Chao, L., Deng, J. & Solar, J. Microfluidic separation, detection, and engineering of extracellular vesicles for most cancers diagnostics and drug supply. Acc. Mater. Res. 3, 498–510 (2022).
